TNXP
Tonix Pharmaceuticals Holding Corp
10.20$
-3.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.9% | -41.5% | -2.7% | -1.6% | -44.7% | +574.4% | +145.4% | -6.3% | -31.6% | +5.5% | +70.2% | |
| – | +18.8% | -41.5% | -2.6% | -1.5% | -46.5% | +530.8% | +114.9% | -30.8% | -63.5% | +149.1% | +92.3% | |
| – | -49.8% | -1.2% | +34.6% | -1.8% | -55.1% | +585.1% | +131.8% | -32.7% | -79.2% | +295.9% | +110.2% | |
| – | +12.7% | -39.3% | -2.4% | -1.8% | -55.1% | +585.1% | +131.8% | -32.7% | -79.2% | +295.9% | +110.2% | |
| – | +444.5% | -86.1% | +26.0% | +6.3% | +92.6% | +654.4% | +1.3% | +4.1% | -42.9% | +72.2% | +23.4% | |
| – | – | – | – | – | – | – | – | – | – | -40.6% | -28.5% | |
| – | +6.7% | -57.1% | -39.3% | -52.7% | -20.9% | +28,808.8% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +8,019.2% | -98.8% | +0.0% | |
| – | +95.8% | -68.2% | -0.5% | +24.2% | +93.6% | +104.9% | +110.6% | -16.6% | +164.4% | -52.3% | +37.2% | |
| – | +96.6% | -68.2% | +0.5% | +24.9% | +93.4% | +91.2% | +121.2% | -16.3% | +3.9% | -3.1% | +68.4% | |
| – | – | – | – | – | – | +69.0% | -17.8% | -11.7% | +506.5% | -89.5% | -54.4% | |
| – | +105.0% | -71.4% | +48.6% | +8.3% | +118.7% | +49.8% | +188.9% | -39.3% | -53.1% | +20.2% | +78.5% | |
| – | – | – | – | – | – | – | – | – | – | -28.9% | – | |
| – | +11.6% | -37.0% | -2.9% | -3.9% | -60.2% | +830.7% | +149.5% | -5.3% | -49.1% | +32.3% | +75.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +100.0% | +100.0% | +150.0% | +70.0% | +1,376.5% | +5,788.4% | +280.8% | -48.1% | +2,613.4% | +9,191.3% | +1,055.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.